A study of over 1300 elderly patients with stage III locally advanced non-small cell lung cancer (NSCLC) suggests that the adjuvant therapy they often receive is providing them with no survival benefit.
This patient population typically undergoes surgery in order to remove the tumor. Yet because surgery can not get clear a patient one hundred percent of cancer, adjuvant therapy is common—whether it is 'mop-up' chemotherapy or radiotherapy—as a means of trying to prevent the possibility of recurrence. In these patients, doctors commonly order postoperative radiation therapy (PORT), despite the fact that this practice is considered controversial.
According to the resultsof this latest study carried out by researchers at Mt. Sinai School of Medicine in New York City and published in the journal Cancer, postoperative radiation therapy provided thesepatients no survival benefit over not receiving PORT, leaving them to call into question the relevance of this practice.
Source: OncLive
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
